Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04244656
Title A Safety and Efficacy Study Evaluating CTX120 in Subjects With Relapsed or Refractory Multiple Myeloma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors CRISPR Therapeutics AG
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | CAN | AUS

Facility Status City State Zip Country Details
University of Chicago Chicago Illinois 60637 United States Details
Oregon Health and Science University Portland Oregon 97239 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Royal Prince Alfred Hospital Sydney New South Wales 2050 Australia Details
Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia Details
University Health Network, Princess Margaret Cancer Centre Toronto Ontario M5G 1X6 Canada Details
Institut Catala d'Oncologia Hospital Germans Trias i Pujol Badalona Barcelona 08916 Spain Details
Universidad de Navarra Pamplona Navarra 31008 Spain Details
Hospital Universitario de Salamanca Salamanca 37007 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field